On 10 February, Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY), a specialty pharmaceutical company focused on the development and commercialization of proprietary compounded drug therapies, announced plans to introduce new patent-pending tiopronin and potassium citrate delayed release (DR) compounded formulations that may be prescribed by physicians as a lower cost therapeutic alternative to FDA-approved Thiola. The formulations are expected to be available to prescribers in April 2016.
Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY) belongs to Healthcare sector. Its weekly performance is 2.25%. On last trading day company shares ended up at $4.09.
Education Realty Trust (NYSE:EDR) reported Net income attributable to common stockholders for the fourth quarter 2015 was $14.8 million, or $0.27 per diluted share, compared to $22.4 million, or $0.47 per diluted share, in the fourth quarter of the prior year. For the full year, net income attributable to common stockholders was $19.9 million, or $0.40 per diluted share, compared to $47.1 million, or $1.09 per diluted share.
Education Realty Trust (NYSE:EDR) shares advanced 2.03% in last trading session and ended the day at $40.30. EDR Gross Margin is 47.70% and its return on assets is 1.50%. Education Realty Trust (NYSE:EDR) quarterly performance is 11.10%.
Enable Midstream Partners, LP (NYSE:ENBL) announced financial results for fourth quarter and full year 2015. Net income attributable to the partnership was $65 million for fourth quarter 2015, a decrease of $57 million compared to $122 million for fourth quarter 2014. The net income attributable to the partnership for fourth quarter 2015 reflects a $29 million non-cash impairment of long-lived assets, including intangible assets.
On 25 February, Enable Midstream Partners, LP (NYSE:ENBL) shares fell -2.60% and was closed at $5.62. ENBL EPS growth in last 5 year was -39.60%. Enable Midstream Partners, LP (NYSE:ENBL) year to date (YTD) performance is -36.29%.
Corcept Therapeutics Incorporated (NASDAQ:CORT) reported preliminary revenue of $15.0 million for the fourth quarter of 2015 and $50.3 million for the full year. Preliminary GAAP net income for the fourth quarter of 2015 was $0.01 per share, compared to a net loss of $0.04 per share in the fourth quarter of 2014. For the full year, the company reported a preliminary GAAP net loss of $0.06 per share for 2015, compared to a net loss of $0.31 per share in 2014.
Corcept Therapeutics Incorporated (NASDAQ:CORT) ended the last trading day at $3.81. Company weekly volatility is calculated as 6.04% and price to cash ratio as 11.35. Corcept Therapeutics Incorporated (NASDAQ:CORT) showed a weekly performance of 0.53%.
Valley National (NYSE: VLY) declared a quarterly dividend of $0.11 per share, or $0.44 annualized. The dividend will be payable on April 1, 2016, to stockholders of record on March 15, 2016, with an ex-dividend date of March 11, 2016.
Valley National Bancorp (NYSE:VLY) shares advanced 1.91% in last trading session and ended the day at $9.06. VLY return on assets is 0.50%. Valley National Bancorp (NYSE:VLY) quarterly performance is -17.40%.